SKB264 with pembrolizumab in subjects with selected solid tumors

A multicenter, open-label, phase 2, basket study to evaluate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with selected solid tumors (SKB264-II-06)

Disease Types: Bladder, Ovarian, Solid Tumors

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A multicenter, open-label, phase 2, basket study to evaluate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with selected solid tumors (SKB264-II-06)

For More Information:

https://clinicaltrials.gov/study/NCT05642780?term=NCT05642780&rank=1